PCOS: What Polycystic Ovary Syndrome Is, Why It Happens, and How It's Managed

Short Answer

Polycystic ovary syndrome is a common hormone-and-metabolism condition in people of reproductive age. Three things tend to travel together: irregular or absent periods, signs of higher-than-usual androgens (such as unwanted hair growth, acne, or scalp hair thinning), and ovaries that can look “polycystic” on ultrasound. You do not need all three to have PCOS: in adults, widely used Rotterdam-based criteria diagnose PCOS when 2 of 3 features are present, after other causes are excluded. That “2 of 3” structure is one reason PCOS can take a while to name. As one review describes it, “Polycystic ovary syndrome (PCOS) is a multifactorial endocrine disorder affecting about 10% of reproductive-age women. It is defined by insulin resistance, androgen excess, and chronic inflammation, which drive both reproductive and metabolic complications” (Patel, *Frontiers in Endocrinology*, PMC12957162) — so it is not only about the ovaries or fertility. WHO estimates PCOS affects about 10–13% of reproductive-aged women globally, and that up to 70% of affected women may be undiagnosed. (WHO)

Underneath the visible symptoms, two engines often reinforce each other: insulin resistance — your body needing to make more insulin to keep blood sugar in range — and higher androgen activity. More insulin can push the ovaries toward more androgen production; more androgen activity can then show up as cycle disruption, acne, excess facial or body hair, or scalp hair thinning. Because of this metabolic side, PCOS is linked over time with higher risk of insulin resistance, type 2 diabetes, unhealthy cholesterol patterns, high blood pressure, sleep apnea, obesity, and cardiovascular risk factors. That is why good care looks at the whole body — glucose, lipids, blood pressure, sleep, mental health, cycle pattern, and fertility goals — not just the ovaries. (WHO)

A wearable or app cannot diagnose PCOS. Current diagnosis depends on your symptoms, medical history, physical exam, bloodwork, and sometimes ultrasound — and clinicians also check for conditions that can mimic PCOS, including thyroid disease, high prolactin, and non-classic congenital adrenal hyperplasia. But tracking sleep, resting heart rate, heart-rate variability (HRV), recovery, and cycle changes over time can still be useful: it gives you a clearer, personal timeline to bring to your clinician, especially when your symptoms feel real but one appointment or one lab snapshot looks “normal.” Welltory records your body signals and helps you see patterns; it does not diagnose PCOS. (Endocrine Society Guideline, PMC5399492)

PCOS at a glance

What PCOS is — and what's happening with your hormones

PCOS is best understood as a whole-body hormonal and metabolic condition, not just “cysts on the ovaries.” The name can be misleading: the “polycystic” look on ultrasound usually means many small follicles, not dangerous disease cysts, and you can still have PCOS without that ultrasound finding because ovarian appearance is only one possible feature of the condition. (Mayo Clinic Press) The core picture is that ovulation becomes irregular or stops, androgen activity runs higher than usual, and — for many people — the body’s handling of insulin is less efficient. As one review summarizes it, “Polycystic ovary syndrome (PCOS) is a multifactorial endocrine disorder affecting about 10% of reproductive-age women. It is defined by insulin resistance, androgen excess, and chronic inflammation, which drive both reproductive and metabolic complications.” (Patel, *Frontiers in Endocrinology*, PMC12957162)

That is why the symptoms can feel connected even when they show up in different places: your skin, hair, cycle, weight, cravings, mood, or fertility. Higher insulin can push the ovaries and adrenal glands toward more androgen production; higher androgen activity can interfere with follicle development and ovulation; disrupted ovulation then shows up as irregular, skipped, or unpredictable periods. (Patel, *Frontiers in Endocrinology*, PMC12957162) Recent reviews describe this as a reinforcing loop rather than a set of separate problems: “these abnormalities are not independent phenomena but components of a self-perpetuating redox-endocrine network that sustains hyperandrogenism, anovulation, and metabolic impairment.” (*Frontiers in Endocrinology*, 2026, PMC13160802) In plain terms: your body is not “broken.” A few signals are stuck amplifying each other — and that also means there are several possible entry points to interrupt the loop.

There is no single cause. PCOS tends to run in families, and research points to genetic and environmental contributors, but the exact cause is still not fully known. (NICHD/NIH) It also involves several biological systems at once. As one pathogenesis review puts it, “The etiology of PCOS involves a complex interplay of genetic, metabolic, hormonal, immunological and environmental factors, though its precise mechanisms remain incompletely understood.” (Chen et al., *Frontiers in Endocrinology*, 2026, PMC12883396) That uncertainty is honest, not evasive: it is why care focuses on identifying your pattern, ruling out look-alike conditions, and managing the drivers you can influence rather than chasing one universal “root cause.” Causes are covered in depth on our PCOS causes page.

How common PCOS is, and who gets it

PCOS is among the most common endocrine conditions in people of reproductive age — especially people who menstruate, including women, girls, and gender-diverse people who may be at risk. WHO estimates that PCOS affects about 10–13% of reproductive-aged women globally, and the 2023 International Evidence-based Guideline reports a similar 10–13% prevalence range. Research papers often use broader ranges because they apply different diagnostic definitions and study different populations: one review states PCOS is “affecting 5-18% of reproductive-aged women, characterized by menstrual irregularities, hyperandrogenism, and polycystic ovarian morphology” (*Frontiers in Medicine*, 2026, DOI 10.3389/fmed.2026.1747593), while another puts it at “about 10% of reproductive-age women” (Patel, *Frontiers in Endocrinology*, PMC12957162). The wide range is not sloppiness — it reflects that different criteria capture different groups, and that many people with PCOS are still missed or diagnosed late. (WHO)

PCOS can become apparent soon after periods begin, but it is often recognized only later, when separate pieces finally get connected: irregular or infrequent periods, acne, oily skin, unwanted facial or body hair, scalp hair thinning, weight changes, or difficulty conceiving. WHO notes that up to 70% of affected women worldwide may not know they have PCOS, which helps explain why someone can live with symptoms for years before the condition gets a name. (WHO)

The symptoms: periods, skin and hair, weight, and mood

PCOS symptoms can look unrelated on the surface, but they often come from the same loop: ovulation becomes less predictable, androgen activity rises, and insulin signaling may be harder for the body to use efficiently. That does not mean everyone gets the same symptom pattern. Some people mainly notice periods. Some notice skin or hair changes. Some have metabolic changes with very few visible signs. (NICHD/NIH)

Irregular, infrequent, or absent periods. This is often the first clue because ovulation is the event that helps set the rhythm of the menstrual cycle. When ovulation is delayed or skipped, bleeding may come late, show up unpredictably, become very heavy, or stop for stretches of time. The same irregular ovulation is also why PCOS can affect fertility: NICHD describes PCOS as the most common cause of anovulatory infertility. (NICHD/NIH)

Signs of higher androgens (hyperandrogenism). Higher androgen activity can show up in places you can see every day: coarser or unwanted hair on the face, chest, belly, or thighs; acne that is severe, late-onset, persistent, or hard to treat; oily skin; or thinning hair at the scalp — the kind of change people often search as “PCOS hair loss,” “hair thinning,” or “hair regrowth.” These signs reflect hormone signaling at hair follicles and oil glands. They are not a hygiene problem, and they are not a willpower problem. (NICHD/NIH)

Weight and “PCOS belly.” Many — though not all — people with PCOS carry extra weight, and weight gain or trouble losing weight around the waist is commonly described. The reason can be partly metabolic: more than half of women with PCOS have insulin resistance, according to NICHD, meaning the body does not respond to insulin as efficiently. When insulin has to work harder, it can interact with appetite, fat storage, androgen production, and energy swings, which is why weight change may feel harder than “just eat less.” Weight, metabolic strategies, and the popular low-GI/low-glycemic angle are covered on our PCOS diet & food and PCOS treatment pages. (NICHD/NIH)

Mood and quality of life. PCOS is not only physical. As one 2026 study frames it, “Polycystic Ovary Syndrome (PCOS) is one of the most common conditions affecting women of reproductive age, significantly impacting both physical and psychological well-being.” (*Frontiers in Endocrinology*, 2026, PMC12773819) In a 2017 meta-analysis of cross-sectional studies, women with PCOS had higher odds of depressive symptoms than controls, including higher odds of moderate-to-severe depressive symptoms; body-image research also finds more appearance- and weight-related distress in people with PCOS compared with those without it. If mood symptoms are intense, persistent, or affecting daily life, they deserve care in their own right — not just as a footnote to hormones. (Cooney et al., *Human Reproduction*, 2017, PMID 28333286)

Insulin resistance and long-term metabolic risk — the part people miss

The metabolic side of PCOS is easy to miss because it may not feel as loud as irregular periods, acne, facial hair, or hair thinning. But it matters for the long game. Many people with PCOS have insulin resistance: your muscles, liver, and fat tissue do not respond to insulin as efficiently, so your pancreas may need to release more of it to keep blood sugar in range. That extra insulin can also signal the ovaries to make more androgens and can lower sex hormone-binding globulin, which may leave more active androgen circulating. In plain language: blood-sugar regulation and “hormone” symptoms are not separate stories — they can feed the same loop. (Dunaif, *Endocrine Reviews*, PMID 9165656)

Over time, PCOS is linked with a higher chance of impaired glucose tolerance and type 2 diabetes, and the 2023 international PCOS guideline states that this risk is increased regardless of age and BMI, though higher weight can add to it. The same guideline recommends assessing glycemic status at diagnosis in adults and adolescents with PCOS; it also notes that an oral glucose tolerance test is the most accurate test for detecting dysglycemia in this population. (2023 International PCOS Guideline, PMC10477934)

The cardiometabolic picture is broader than blood sugar. PCOS is associated with more cardiovascular risk factors — including dyslipidemia, high blood pressure, impaired glucose tolerance, gestational diabetes, and metabolic syndrome — which is why good PCOS care looks at metabolic health, not only cycle tracking or androgen symptoms. Endocrine Society guidance recommends screening people with PCOS for cardiovascular disease risk factors such as family history, smoking, impaired glucose tolerance/type 2 diabetes, hypertension, dyslipidemia, sleep apnea, and obesity, especially abdominal adiposity. (Endocrine Society Guideline, PMC5399492)

That does not mean PCOS guarantees diabetes or heart disease. It means your risk map deserves attention earlier. Lifestyle steps that improve insulin sensitivity — nutrition patterns you can sustain, regular movement, sleep, and weight management when relevant — can help several parts of the syndrome at once because they act on the shared metabolic loop, not just on one symptom. Specific screening intervals, thresholds, and medication decisions — for example, whether and when to use insulin-sensitizing medication — are individual clinical decisions set with a clinician. See our PCOS treatment page and talk to your clinician.

How PCOS is diagnosed

There is no single “PCOS test.” Diagnosis is made from a pattern your clinician can see across your history, symptoms, exam, and sometimes imaging or lab results. In adults, clinicians most often use the Rotterdam framework: PCOS is generally diagnosed when two of three features are present — irregular or absent ovulation, clinical or blood-test signs of higher androgens, and polycystic-appearing ovaries — after other conditions that can look similar have been checked for and excluded. Those look-alikes commonly include thyroid disease, high prolactin, and non-classic congenital adrenal hyperplasia; depending on your symptoms, a clinician may also consider other causes of missed periods or androgen excess. (Endocrine Society Guideline, PMC5399492)

In practice, the workup usually starts with a conversation: how often you bleed, how predictable your cycles are, whether you have acne, facial or body hair growth, scalp hair thinning, weight changes, fertility concerns, or symptoms that point away from PCOS. Then comes an exam and bloodwork — often including androgens and tests used to rule out look-alikes, plus metabolic labs because PCOS can travel with insulin resistance and cardiometabolic risk. A pelvic ultrasound may be used to look at the ovaries and uterine lining, but it is not always required; if irregular ovulation and hyperandrogenism are already clear, diagnosis may not need ultrasound. (Mayo Clinic)

Adolescents are handled more carefully. In the first years after periods begin, acne, cycle irregularity, and changing hormone patterns can be part of normal puberty, so adult-style criteria can overcall PCOS. Current international guidance says adolescents should not be diagnosed based on ovarian ultrasound appearance or AMH alone; the pattern needs to be interpreted with age and time since first period in mind. The full diagnostic workup is on our PCOS diagnostic page. (International PCOS in Adolescents Guideline, PMC11899933)

Where tracking fits. A wearable cannot confirm or rule out PCOS, because PCOS diagnosis depends on clinical features, lab context, and exclusion of other conditions. But tracking can make the story easier to tell. Cycle length and variability, sleep quality, resting heart rate, HRV, and recovery trends can turn “something feels off” into a timeline you can bring to an appointment. That context may help your clinician ask sharper questions — it is not a diagnosis. Welltory tracks and records your body signals; only a qualified clinician can diagnose a condition.

How PCOS is managed (overview)

There is no cure for PCOS, but that does not mean you are stuck with every symptom. Treatment can help manage irregular cycles, acne or excess hair growth, fertility concerns, insulin resistance, weight-related risk, and long-term metabolic health. The right plan depends on what matters most to you right now — more predictable bleeding, skin and hair changes, trying to get pregnant, lowering diabetes risk, or feeling more stable day to day — and it should be chosen with a clinician who can check risks, contraindications, and your labs. Current guideline summaries emphasize shared decision-making, education, lifestyle support, and targeted medical therapy rather than one universal PCOS plan. (2023 International PCOS Guideline, PMC10477934)

Lifestyle work is usually the foundation because PCOS often runs through insulin signaling: when your muscles, liver, and fat tissue respond less efficiently to insulin, the body may make more of it, and higher insulin can push the ovaries toward higher androgen production. So nutrition patterns, regular movement, sleep, and stress load are not “wellness extras” — they are levers that can affect cycles, cravings, energy, glucose, lipids, and androgen-driven symptoms at the same time. A low-glycemic-index approach is popular because it aims to flatten glucose and insulin spikes, but the 2023 international guideline also notes that no single diet pattern is clearly best for everyone with PCOS; the useful plan is the one that supports your health and is sustainable in your real life. (2023 International PCOS Guideline, PMC10477934)

Even modest, sustainable changes can help cycle regularity and metabolic markers, especially when they improve insulin sensitivity. As an illustration of how much cycle function can respond to metabolic change, one 12-week intervention study in women with obesity and PCOS reported that “menstrual regularity improved in 80% of participants, and 50% showed improved ovulation frequency” — though this was a single, non-randomized study in a specific group (90 obese women with PCOS), not a promise for everyone. (An et al., *Frontiers in Endocrinology*, 2026, PMID 41928885)

Medication choices — combined hormonal birth control for cycle and androgen symptoms, insulin-sensitizing medication such as metformin, anti-androgens such as spironolactone, and fertility-specific treatments — have real benefits, risks, and contraindications, and are not one-size-fits-all. They are individualized by a clinician; don't self-adjust, and consult your physician. Guideline-based summaries describe combined oral contraceptive pills as a common first-line pharmacologic option for menstrual irregularity and hyperandrogenism, metformin as mainly used for metabolic features or insulin resistance, anti-androgens as options for androgen-related hair or skin symptoms, and ovulation-induction treatment when pregnancy is the goal. Some options are off-label for PCOS, and some are unsafe in pregnancy unless contraception is used, so this overview does not recommend, dose, or compare specific drugs. For a detailed, medically reviewed treatment breakdown (including "birth control pills for PCOS," "metformin for PCOS," "spironolactone with PCOS," and getting pregnant with PCOS), see our PCOS treatment page and decide with your clinician. (Pharmacological management review, PMC11368538)

How we made it

Made with AI tools, then edited, fact-checked, and medically reviewed by the Welltory team. We grounded the article in current PCOS guidance and primary medical sources: PCOS is generally framed around ovulatory dysfunction, higher androgen activity, and sometimes polycystic ovarian morphology; in adults, diagnosis is clinical and requires excluding look-alike conditions rather than relying on one single test. We also checked the metabolic framing, because insulin resistance is common in PCOS and is part of why clinicians often monitor long-term risks such as type 2 diabetes and cardiovascular risk factors.

For this article, no Welltory cohort figure was published. Our dataset does not include a self-reported PCOS flag, so we did not generate, estimate, or imply any PCOS-specific numbers from user data. Any physiological signals we mention — sleep, resting heart rate, HRV, recovery, or cycle changes — are described only as general context you can bring to a qualified clinician. All figures are reported as anonymized, aggregated data; no individual user is identifiable. Welltory does not diagnose PCOS.

Discounts for blog readers: up to 36% off

See what affects your energy, stress, sleep, and daily state with Welltory

Explore your data